BriaCell Therapeutics Corp. (TSX:BCT)
4.740
-0.060 (-1.25%)
Aug 14, 2026, 12:24 PM EST
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of CAD 41.15 million as of August 14, 2026. Its market cap has increased by 136.83% in one year.
Market Cap
41.15M
Enterprise Value
9.22M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.74
ChartMarket Cap Chart
Since December 3, 2014, BriaCell Therapeutics's market cap has increased from 24.42M to 41.15M, an increase of 68.53%. That is a compound annual growth rate of 4.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 41.15M | 122.89% |
| Dec 31, 2025 | 18.46M | -48.44% |
| Dec 31, 2024 | 35.81M | -71.28% |
| Dec 29, 2023 | 124.66M | 36.15% |
| Dec 30, 2022 | 91.56M | -44.85% |
| Dec 31, 2021 | 166.03M | 3,496.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MedMira | 45.61M |
| Microbix Biosystems | 44.08M |
| NurExone Biologic | 43.74M |
| Sona Nanotech | 43.59M |
| Sernova Biotherapeutics | 43.43M |
| Onco-Innovations | 37.57M |
| Medicenna Therapeutics | 37.38M |
| Resverlogix | 34.38M |